Form 8.3 -ALLIANCE PHARMA PLC

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.

Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy

To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.

FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
Rule 8.3 of the Takeover Code (the "Code")
1.				KEY INFORMATION
(a)	Full name of discloser:				Barclays PLC.
(b)	Owner or controller of interest and short
	positions disclosed, if different from 1(a):
(c)	Name of offeror/offeree in relation to whose				ALLIANCE PHARMA PLC
	relevant securities this form relates:
(d)	If an exempt fund manager connected with an
	offeror/offeree, state this and specify identity of
	offeror/offeree:
(e)	Date position held/dealing undertaken:				24 Mar 2025
(f)	In addition to the company in 1(c) above, is the discloser making				NO
	disclosures in respect of any other party to the offer?
2.				POSITIONS OF THE PERSON MAKING THE DISCLOSURE
(a)	Interests and short positions in the relevant securities of the offeror or offeree
	to which the disclosure relates following the dealing(if any)
Class of relevant security:				1p ordinary
				Interests		Short Positions
				Number	(%)	Number	(%)
(1)	Relevant securities owned
	and/or controlled:			4,803,342	0.89%	1,290,397	0.24%
(2)	Cash-settled derivatives:
	and/or controlled:			599,917	0.11%	4,766,081	0.88%
(3)	Stock-settled derivatives (including options)
	and agreements to purchase/sell:			0	0.00%	0	0.00%

	TOTAL:			5,403,259	1.00%	6,056,478	1.12%
(b)	Rights to subscribe for new securities (including directors and other executive
	options)
Class of relevant security in relation to
which subscription right exists
Details, including nature of the rights
concerned and relevant percentages:
3.				DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER
(a)	Purchases and sales
Class of relevant		Purchase/sale		Number of		Price per unit
security				securities
1p ordinary		Purchase		166,872		0.6410 GBP
1p ordinary		Purchase		122,597		0.6418 GBP
1p ordinary		Purchase		6,211		0.6420 GBP
1p ordinary		Purchase		4,778		0.6409 GBP
1p ordinary		Purchase		4,297		0.6415 GBP
1p ordinary		Sale		98,017		0.6410 GBP
1p ordinary		Sale		16,492		0.6409 GBP
1p ordinary		Sale		6,211		0.6420 GBP

(b)	Cash-settled derivative transactions
Class of		Product		Nature of dealing		Number of	Price per
relevant		description				reference	unit
security						securities
1p ordinary		SWAP		Decreasing Short		16,492	0.6409 GBP
1p ordinary		SWAP		Decreasing Short		90,918	0.6410 GBP
1p ordinary		SWAP		Increasing Short		6,799	0.6410 GBP
1p ordinary		SWAP		Increasing Short		114,977	0.6413 GBP
1p ordinary		SWAP		Increasing Short		118,697	0.6415 GBP
1p ordinary		CFD		Increasing Short		53,293	0.6410 GBP

(c)	Stock-settled derivative transactions (including options)
(i)	Writing, selling, purchasing or varying
Class	Product	Writing,	Number	Exercise	Type	Expiry	Option
of	description	purchasing,	of	price		date	money
relevant		selling,	securities	per unit			paid/
security		varying etc	to which				received
			option				per unit
			relates


(ii)	Exercising
Class of relevant		Product description		Exercising/ exercised against		Number of	Exercise price per
security						securities	unit


(d)	Other dealings (including subscribing for new securities)
Class of relevant		Nature of Dealings		Details		Price per unit (if
security						applicable)

4.				OTHER INFORMATION
(a)	Indemnity and other dealings arrangements
Details of any indemnity or option arrangement, or any agreement or understanding,
formal or informal, relating to relevant securities which may be an inducement to deal
or refrain from dealing entered into by the exempt principal trader making the disclosure and any party
to the offer or any person acting in concert with a party to the offer:
NONE
(b)	Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal, between
the person making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights of future acquisition or disposal of any relevant securities to which
any derivative is referenced:
NONE
(c)	Attachments
Is a Supplemental Form 8 (Open Positions) attached?				NO
Date of disclosure:				25 Mar 2025
Contact name:				Large Holdings Regulatory Operations
Telephone number:				020 3134 7213

Companies

UK 100

Latest directors dealings